Baseline characteristics of all three trials
| SRD trial | MRD trial | Bioavailability trial | |
| Subjects | 56 | 50 | 12 |
| Age years | 34.7±8.8 (21–51) | 32.8±6.6 (21–45) | 36.8±9.5 (23–49) |
| Race | |||
| White | 55 (98.2) | 48 (96.0) | 12 (100) |
| Black/African American | 1 (1.8) | 1 (2.0) | 0 |
| Asian | 0 | 1 (2.0) | 0 |
| Hispanic/Latino | |||
| No | 55 (98.2) | 50 (100) | 12 (100) |
| Yes | 1 (1.8) | 0 | 0 |
| BMI kg·m−2 | 26.8±2.3 | 24.6±2.8 | 25.1±2.6 |
Data are presented as n, mean±sd (range) or n (%). SRD: single-rising-dose; MRD: multiple-rising-dose; BMI: body mass index.